HMG-CoA reductase inhibitors: role in normal and malignant cells
- 1 April 1996
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 22 (3) , 197-212
- https://doi.org/10.1016/1040-8428(96)00193-x
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- 7α-Hydroxylation of 25-hydroxycholesterol and 27-hydroxycholesterol in human fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Inhibition of growth factor signaling pathways by lovastatinBiochemical and Biophysical Research Communications, 1991
- Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: Possible role in membrane localizationBiochemical and Biophysical Research Communications, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Cell cycle regulation of human diploid fibroblasts: Possible mechanisms of platelet‐derived growth factorJournal of Cellular Physiology, 1989
- Antiestrogen binding sites: General and comparative propertiesJournal of Steroid Biochemistry, 1988
- Cholesterol hydroperoxides inhibit calmodulin and suppress atherogenesis in rabbitsBiochemical and Biophysical Research Communications, 1987
- Prenylated proteins from kidneyBiochemical and Biophysical Research Communications, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Antagonistic action of cholesterol towards the toxicity of hydroxysterols on cultured hepatoma cellsBiochemical and Biophysical Research Communications, 1984